-
Company Insights
NewInnovation and Patenting activity of Syneos Health Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Syneos Health Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Lennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Lennox-Gastaut Syndrome Clinical Trials Market Overview The Lennox-Gastaut Syndrome clinical trial market research report provides an overview of the Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top-line data relating to the clinical trials on Lennox-Gastaut Syndrome. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The...
-
Company Profile
Syneos Health Inc – Company Profile
Syneos Health Inc (Syneos Health), formerly INC Research Holdings Inc, is a biopharmaceutical services organization that offers product development and commercial solutions. The company provides clinical development services spanning Phase I to Phase IV, such as full-service global studies, clinical monitoring, patient recruitment, investigator recruitment, data management, and other services. Its commercial solutions include communications, medication adherence and consulting services. Syneos Health offers its solutions for large and small to mid-sized companies across biotechnology, biopharmaceutical, and medical device industries. The...
Add to Basket -
Product Insights
Clinical Trials – Precision and Personalized Medicine
This report provides analysis of clinical research involving precision and personalized medicines and identifies trends throughout the years. The terms precision and personalized medicine are often used interchangeably as they refer to similar types of treatment. They both define the stratification of patients within a disease segment using their genomic and phenotypic variations to find targeted therapies. This is an alternative to the traditional process of drug design, which typically follows a one-size-fits all approach. Precision and personalized medicine is...
-
Product Insights
Tourette Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Tourette Syndrome Clinical Trials Market Report Overview The Tourette Syndrome clinical trial market research report provides an overview of the Tourette Syndrome Clinical trials scenario. This report provides top-line data relating to the clinical trials on Tourette Syndrome and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Thematic Analysis
Precision and Personalized Medicine in Pharma – Thematic Intelligence
Precision and Personalized Medicine in Pharma Thematic Report Overview Precision and personalized medicine have already begun to reshape disease treatment paradigms and the provision of healthcare. Improved patient outcomes, increased quality of life, reduced financial and time expenditure of disease management with curative therapies, and a shift from reactive to proactive care are all driving investment in R&D in this space. The precision and personalized medicine in pharma thematic intelligence report provides a focused chapter on the key healthcare, technology,...
-
Product Insights
Alpha-1 Antitrypsin Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Alpha-1 Antitrypsin Deficiency Clinical Trials Market Overview The A1AD clinical trial market research report provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha-1 Antitrypsin Deficiency (A1AD). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status...
-
Product Insights
Obsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Obsessive-Compulsive Disorder Clinical Trials Market Report Overview The Obsessive-Compulsive Disorder clinical trial market research report provides an overview of the Obsessive-Compulsive Disorder clinical trials scenario. The report provides top-line data relating to the clinical trials on Obsessive-Compulsive Disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Product Insights
IgA Nephropathy Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
IgA Nephropathy Clinical Trials Market Report Overview The IgA Nephropathy clinical trial market research report provides an overview of the IgA Nephropathy clinical trials scenario. The report provides top-line data relating to the clinical trials on IgA Nephropathy. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....